#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Non-small cell lung cancer metastatic Type 2 diabetes mellitus More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dilated cardiomyopathy Fibrous dysplasia of bone Renal transplant Polyneuropathy Autoimmune demyelinating disease Cardiac sarcoidosis Neuroendocrine cell hyperplasia of infancy Nephrotic syndrome Nodal marginal zone B-cell lymphoma Glomerulonephritis membranous Transient ischaemic attack Dermatitis Sickle cell anaemia Nephroblastoma Mantle cell lymphoma stage III More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Diagnostics Alagille syndrome – Diagnostics Sarcoidosis – Basic Information Mucopolysaccharidosis – Life with Disease Von Willebrand’s disease – Treatment Primary immunodeficiency syndrome Methylmalonic acidaemia – Basic Information Pleomorphic leiomyosarcoma – Life with Disease Cholangitis sclerosing – Treatment Primary mediastinal large B-cell lymphoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adapalene Oxytocin Synthetic Dorzolamide Hydrochloride Ganaxolone Metoprolol Dobutamine Hydrochloride Contezolid GSKVX000000034792 Dupilumab ULVIPRUBART Retifanlimab Bhv-7000 Glyceryl Trinitrate Valbenazine Ditosylate Azathioprine ZIMISLECEL Fenofibrate Micronised Diclofenac Epolamine Ide397 Dextrose Bp More therapies…

    Learn about Your Condition

    Malignant fibrous histiocytoma Cardiovascular disorder Vesicoureteric reflux Hypertrophic scar Chondropathy Vulvovaginal pruritus Mesothelioma malignant Stevens-Johnson syndrome Polycystic ovarian syndrome Venous thrombosis limb Metachromatic leukodystrophy Menopausal symptoms Retinal artery occlusion Muscle strain Gestational diabetes More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Everolimus-Based Calcineurin-Inhibitor-Free Immunosuppression with Drug Combination in Patients One Year After Liver Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Everolimus
    • Ciclosporin
    • Mycophenolate Mofetil
    Germany

  • A study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • HLX43
    France Italy Poland Romania Spain

  • Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • Tisagenlecleucel
    • Ciltacabtagene Autoleucel
    • Axicabtagene Ciloleucel
    Belgium

  • Effect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute kidney injury
    • Critical illness
    Investigated Drugs:
    • MALIC ACID
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Germany

  • Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Empagliflozin
    France

  • Study of Piperacillin and Tazobactam Given Under the Skin Compared to a Vein in Patients with Infectious Diseases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Piperacillin
    • Tazobactam
    Italy
1 2 3 … 25
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!